Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients with Myelodysplastic Syndromes/Neoplasms (MDS): An Analysis from the International Consortium for MDS (icMDS) Validate Database
Benjamin Rolles(Brigham and Women's Hospital), Valeria Santini(Azienda Ospedaliero-Universitaria Careggi), Gail J. Roboz(Cornell University), Ιoannis Kotsianidis(Democritus University of Thrace), Anoop Enjeti(Hunter Medical Research Institute), Hetty E. Carraway(Cleveland Clinic), Hayley Hawkins(Vanderbilt University Medical Center), David Valcárcel(Vall d'Hebron Hospital Universitari), Claudia Haferlach(Munich Leukemia Laboratory (Germany)), David A. Sallman(Moffitt Cancer Center), Constantine Logothetis(Saint Louis University), Amy E. DeZern(Johns Hopkins University), Eunice S. Wang(Roswell Park Comprehensive Cancer Center), Tariq Kewan(Yale University), Joshua F. Zeidner(University of North Carolina at Chapel Hill), Somedeb Ball(Vanderbilt University), Maria L. Amaya(University of Colorado Denver), Torsten Haferlach(Martin Luther Christian University), Jessica M. Stempel(University of New Haven), Zhuoer Xie(Mayo Clinic), Ondřej Bláha(Yale University), Michael R. Savona(Vanderbilt University), Lisa Pleyer(Paracelsus Medical University), Mikkael A. Sekeres(University of Miami), Stacey M. Frumm(Dana-Farber Cancer Institute), Devendra Hiwase(Australasian Leukaemia and Lymphoma Group), Namrata S. Chandhok(Sylvester Comprehensive Cancer Center), Elizabeth A. Griffiths(Roswell Park Comprehensive Cancer Center), María Díez‐Campelo(Complejo Hospitalario de Salamanca), Khalid Halahleh(King Hussein Cancer Center), Eytan M. Stein(Memorial Sloan Kettering Cancer Center), Christine M. McMahon(Albert Einstein College of Medicine), Pinkal Desai(NewYork–Presbyterian Hospital), Talha Badar(Mayo Clinic in Florida), Andrew M. Brunner(Massachusetts General Hospital), Jan Philipp Bewersdorf(Memorial Sloan Kettering Cancer Center), Jaroslaw P. Maciejewski(Cleveland Clinic), Justin Grenet(Cornell University), Luca Lanino(Humanitas University), Yazan F. Madanat(The University of Texas Southwestern Medical Center), Rory M. Shallis(Smilow Cancer Hospital), Geoffrey L. Uy(Memorial Sloan Kettering Cancer Center), Amyah C. Harris(Harvard University), Najla H. Al Ali(Moffitt Cancer Center), Shougat Barua(Dana-Farber Cancer Institute), Vassiliki Pappa(University General Hospital Attikon), Ted M. Getz(Yale Cancer Center), Kamal Al-Rabi(King Hussein Cancer Center), Aram Bidikian(University of New Haven), Yasmin Abaza(Northwestern University)
Cited by 5
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k